Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thota Ganesh

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
ACS Chemical Neuroscience|April 24, 2020
An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 ReceptorsChunxiang Jiang, Radhika Amaradhi, Thota Ganesh, et al.
Journal of Medicinal Chemistry|April 30, 2014
Lead optimization studies of cinnamic amide EP2 antagonistsThota Ganesh, Jianxiong Jiang, Myung-Soon Yang, et al.
ACS Chemical Neuroscience|January 3, 2018
Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2Jianxiong Jiang, Tri Minh Van, Thota Ganesh, et al.
Neurobiology of Disease|March 1, 2019
A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibitionAsheebo Rojas, Thota Ganesh, Wenyi Wang, et al.
Neuropharmacology|August 2, 2016
Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in ratsAsheebo Rojas, Thota Ganesh, Zahra Manji, et al.
Analytical Biochemistry|November 14, 2006
Promotion of tubulin assembly by poorly soluble taxol analogsShubhada Sharma, Thota Ganesh, David G I Kingston, et al.
Antioxidants (Basel, Switzerland)|September 28, 2023
Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective AgentsMatea Juric, Varun Rawat, Radhika Amaradhi, et al.
Molecular Pharmaceutics|November 7, 2018
Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory PropertiesThota Ganesh, Avijit Banik, Ray Dingledine, et al.
Neuropharmacology|February 7, 2015
Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticusAsheebo Rojas, Thota Ganesh, Nadia Lelutiu, et al.
Expert Opinion on Therapeutic Targets|November 29, 2018
The COX-2/prostanoid signaling cascades in seizure disordersAsheebo Rojas, Di Chen, Thota Ganesh, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
ACS Chemical Neuroscience|April 24, 2020
An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 ReceptorsChunxiang Jiang, Radhika Amaradhi, Thota Ganesh, et al.
Journal of Medicinal Chemistry|April 30, 2014
Lead optimization studies of cinnamic amide EP2 antagonistsThota Ganesh, Jianxiong Jiang, Myung-Soon Yang, et al.
ACS Chemical Neuroscience|January 3, 2018
Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2Jianxiong Jiang, Tri Minh Van, Thota Ganesh, et al.
Neurobiology of Disease|March 1, 2019
A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibitionAsheebo Rojas, Thota Ganesh, Wenyi Wang, et al.
Neuropharmacology|August 2, 2016
Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in ratsAsheebo Rojas, Thota Ganesh, Zahra Manji, et al.
Analytical Biochemistry|November 14, 2006
Promotion of tubulin assembly by poorly soluble taxol analogsShubhada Sharma, Thota Ganesh, David G I Kingston, et al.
Antioxidants (Basel, Switzerland)|September 28, 2023
Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective AgentsMatea Juric, Varun Rawat, Radhika Amaradhi, et al.
Molecular Pharmaceutics|November 7, 2018
Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory PropertiesThota Ganesh, Avijit Banik, Ray Dingledine, et al.
Neuropharmacology|February 7, 2015
Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticusAsheebo Rojas, Thota Ganesh, Nadia Lelutiu, et al.
Expert Opinion on Therapeutic Targets|November 29, 2018
The COX-2/prostanoid signaling cascades in seizure disordersAsheebo Rojas, Di Chen, Thota Ganesh, et al.
Pageof 7